AtriCure (ATRC)
(Delayed Data from NSDQ)
$40.96 USD
-0.37 (-0.90%)
Updated Feb 6, 2025 04:00 PM ET
After-Market: $40.98 +0.02 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/12/2025
Time: AMC |
12/2024 | $-0.20 | -100.00% |
Earnings Summary
For their last quarter, AtriCure (ATRC) reported earnings of -$0.17 per share, beating the Zacks Consensus Estimate of $-0.20 per share. This reflects a positive earnings surprise of 15.00%. Look out for ATRC's next earnings release on February 12, 2025. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 4.76%.
Earnings History
Price & Consensus
Zacks News for ATRC
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know
ATRC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last?
AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates
ATRC FAQs
AtriCure, Inc. (ATRC) has announced they will report their next quarter earnings on February 12, 2025. For the next earning release, we expect the company to report earnings of $-0.20 per share, reflecting a year-over-year increase of 4.76%.
AtriCure, Inc. has announced they will report their previous quarter earnings after the close of the market on February 12, 2025.
The Zacks Consensus Estimate for AtriCure, Inc. (ATRC) for the quarter ending in December 2024 is $-0.20 a share. We expect AtriCure, Inc. to miss by -100.00%.
In the earnings report for the quarter ending in September 2024, AtriCure, Inc. (ATRC) announced earnings of $-0.17 per share versus the Zacks Consensus Estimate of $-0.20 per share, representing a surprise of -15.00%.